Moderately active
Showing 1 - 25 of >10,000
Transfemoral Amputation Trial in Wiesbaden (Amputation-specialized rehabilitation, Non-amputation-specialized rehabilitation)
Recruiting
- Transfemoral Amputation
- Amputation-specialized rehabilitation
- Non-amputation-specialized rehabilitation
-
Wiesbaden, GermanyMEDIAN Clinics
Sep 13, 2023
Oxidative Stress, Inflammation Trial in Corciano (Ozonized vegetable oil with vitamines)
Active, not recruiting
- Oxidative Stress
- Inflammation
- Ozonized vegetable oil with vitamines
-
Corciano, Perugia, ItalyCrabion srl
Oct 20, 2022
Muscle Soreness, Pain, Muscle Damage Trial in Cork (Turmipure Gold®, Placebo)
Completed
- Muscle Soreness
- +2 more
- Turmipure Gold®
- Placebo
-
Cork, IrelandAtlantia Food Clinical Trials
Dec 9, 2022
Pain, Acute, Pain, Chronic, Knee Osteoarthritis Trial in La Ñora (COLLAGEN (COL), PLACEBO (PLA))
Recruiting
- Pain, Acute
- +3 more
- COLLAGEN (COL)
- PLACEBO (PLA)
-
La Ñora, Murcia, SpainResearch Center for High Performance Sport. Catholic University
Jun 14, 2023
Ulcerative Colitis Trial (Tilpisertib Fosmecarbil, Placebo)
Not yet recruiting
- Ulcerative Colitis
- Tilpisertib Fosmecarbil
- Placebo
- (no location specified)
Sep 1, 2023
Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)
Not yet recruiting
- Crohn's Disease
- Risankizumab SC
- Placebo for risankizumab
- (no location specified)
Sep 26, 2023
Rheumatoid Arthritis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )
Completed
- Rheumatoid Arthritis
- LNK01001 Dose A
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Oct 24, 2023
Ulcerative Colitis, Ulcerative Colitis Chronic Trial (Mirikizumab)
Not yet recruiting
- Ulcerative Colitis
- Ulcerative Colitis Chronic
- (no location specified)
Mar 6, 2023
Ulcerative Colitis Trial (Mirikizumab IV, Mirikizumab SC)
Not yet recruiting
- Ulcerative Colitis
- Mirikizumab IV
- Mirikizumab SC
- (no location specified)
Mar 24, 2023
Ulcerative Colitis Trial (IV MK-7240, IV Placebo, SC MK-7240)
Not yet recruiting
- Ulcerative Colitis
- IV MK-7240
- +3 more
- (no location specified)
Sep 27, 2023
Ulcerative Colitis Trial in Whittier (APL-1401, Placebo)
Not yet recruiting
- Ulcerative Colitis
- APL-1401
- Placebo
-
Whittier, CaliforniaNew Hope Research Development
Feb 15, 2023
Ulcerative Colitis Trial (Efavaleukin alfa, Placebo)
Not yet recruiting
- Ulcerative Colitis
- Efavaleukin alfa
- Placebo
- (no location specified)
Jan 3, 2023
Crohn's Disease Trial in Warszawa (CT-P13 SC (Infliximab), Placebo SC)
Active, not recruiting
- Crohn's Disease
- CT-P13 SC (Infliximab)
- Placebo SC
-
Warszawa, PolandWIP Warsaw IBD Point Profesor Kierkus
Dec 6, 2022
Ulcerative Colitis Trial in United States (ALTB-268)
Recruiting
- Ulcerative Colitis
- ALTB-268
-
Wellington, Florida
- +6 more
Nov 6, 2023
Disease Activity and Adverse Events in Adolescent and Adult
Recruiting
- Crohn's Disease
-
Toyota-shi, Aichi, Japan
- +1 more
Aug 29, 2023
Safety of Filgotinib in Ulcerative Colitis (UC)
Not yet recruiting
- Ulcerative Colitis
-
Pierre-Bénite, FranceCentre Hospitalier Lyon Sud
Apr 18, 2023
IBD, Colitis, Ulcerative Trial in Australia, United States (MORF-057, Placebo)
Recruiting
- Inflammatory Bowel Diseases
- Colitis, Ulcerative
- MORF-057
- Placebo
-
Sun City, Arizona
- +13 more
Jan 24, 2023
Ulcerative Colitis Trial in Worldwide (BT051 200 mg, BT051 800 mg, BT051 3200 mg)
Completed
- Ulcerative Colitis
- BT051 200 mg
- +3 more
-
Rialto, California
- +5 more
Dec 13, 2022
Ulcerative Colitis, Crohn's Disease Trial (Vedolizumab IV, Vedolizumab SC)
Not yet recruiting
- Ulcerative Colitis
- Crohn's Disease
- Vedolizumab IV
- Vedolizumab SC
- (no location specified)
Oct 17, 2023
Ulcerative Colitis Trial (Intravenous (IV) infusions)
Not yet recruiting
- Ulcerative Colitis
- Intravenous (IV) infusions
- (no location specified)
Mar 14, 2023